Page 571 - Multidisipliner Covid 19
P. 571

COVID-19 Pandemisi ve Kalp-Damar Sistemi


                       al. SARS-koronaviru_s modulation of myocardial ACE2 expres- sion
                       and inflammation in patients with SARS. Eur J Clin Invest 2009;39:
                       618–25.
                   22.  Zeng JH, Liu Y, Yuan J, Wang F, Wu W, et al. First Case of COVID-19
                       Infection with Fulminant Myocarditis Complication: CaseReport and
                       Insights. Preprints Mar 11, 2020. [Epub ahead of print], doi: 10.20944/
                       preprints 2020.03.0180.v1.
                   23. WF, Tang X, Zhao XX. An ‘asymptomatic’ driver with COVID-19:
                       atypical suspected myocarditis by SARS-CoV-2. 2020.Available at:
                       file:///Users/minideniz/Downloads/cdt-10-02-242.pdf. Accessed
                       Apr 27
                   24. Ma KL, Liu ZH, Cao CF, Liu MK, Liao J, Zou JB, et al. COVID-19
                       Myocarditis and Severity Factors: An Adult Cohort Study. MedRxiv
                       2020 MAR 19. [Epub ahead of print], doi: https://doi.org/10.1101/
                       2020.03.19.20034124.
                   25.  Alida LP, Pankuweit S, Arbustini E, et al. Cur- rent state of knowledge
                       on aetiology, diagnosis,management, and therapy of myocarditis: a
                       position statement of the European society of cardiology Working
                       Group on Myocardial and Pericardial Disease. Eur Heart J. 2013;34:
                       2636-48.
                   26. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for
                       the diagnosis and treat- ment of acute and chronic heart failure 2012:
                       the Task Force for the diagnosis and treat- ment of acute and chronic
                       heart failure 2012 of the European Society of Cardiology. Devel- oped
                       in collaboration with the Heart Failure Association of the ESC (HFA).
                       Eur Heart J. 2012;33:1787-847.
                   27.   ESC Guidance for the Diagnosis and Management of CV Disease dur-
                       ing the COVID-19 Pandemic Last updated on 21 April 2020. © The
                       European Society of Cardiology.
                   28. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng
                       Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristicsof
                       138 Hospitalized Patients With 2019 Novel Coronavirus-Infected
                       Pneumonia in Wuhan, China. JAMA 2020 Feb 7. [Epub
                       ahead of print], doi: 10.1001/jama.2020.1585.
                   29.  Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
                       of patients infected with 2019 novel coronavirus in Wuhan, China.
                       Lancet 2020;395:497–506.




                       570
   566   567   568   569   570   571   572   573   574   575   576